On 19 June, SHINE’s CEO joined colleagues from across Europe in Vienna, Austria, to discuss how innovation, collaboration and patient involvement can shape the future of care in cardio-oncology.
At the European Society of Cardiology Congress, Carina Dantas shared insights into the MAYA Project and work on Patient and Public Engagement, Living Labs and co-research methodologies during the session “CARDIOCARE: AI-powered Cardio-Oncology Pathway for All Ages”. Collectively, the project is exploring how adolescent and young adult cancer survivors can become active partners in designing digital solutions aimed at supporting their long-term cardiovascular health.
The MAYA project is based on the belief that meaningful innovation happens with people, not simply for them. By involving patients, carers, healthcare professionals, researchers and communities through Living Labs and co-creation approaches, we can ensure that AI-based healthcare tools are relevant, reliable, inclusive and responsive to real-world needs.
Advances in cardio-oncology require not only technological innovation, but also a genuine partnership with those whose lives are most affected by these challenges.
Carina also led the session “MAYA in Practice: AI, Living Labs and Social Innovation for AYA Survivors” on behalf of SHINE. “As cancer survival rates continue to improve, we must also focus on what comes next: supporting Adolescents and Young Adults (AYA) living beyond cancer. Their journey often extends far beyond treatment, involving long-term physical, emotional, social, and cardiovascular challenges”, says the CEO.
By bringing together technology, healthcare, research and lived experience, the project aims to empower AYA cancer survivors so that they can thrive throughout their journey as survivors. The growing recognition of survivorship and digital innovation within the field of cardio-oncology is encouraging and highlights the importance of collaborative European initiatives such as MAYA.
Learn more about MAYA: https://maya-horizon.eu/